WebSite
RIKEN BRC
Technology and Development Team for BioSignal Program
Subream for Manipulation of Cell Fate
Profile  
   Stem cells are defined as undifferentiated cells capable of making identical copies of themselves and giving rise to specialized cells that make up the tissues and organs of the body. The potential use of stem cells for regenerative therapy is enormous, but before they can be used clinically, the mechanisms that regulate their proliferation and differentiation must be clarified. We are studying to identify the signals that control stem cell fate and hope to develop technologies for manipulating stem cells in vitro.

Dr.Miyoshi
Head
Hiroyuki MIYOSHI,
Ph.D.

Development of Technology
  • Development of methods to expand hematopoietic stem cells in vitro
  • Development of lentiviral vectors for stem cell biology
Projects
  1. Studies on the proliferation and differentiation of hematopoietic stem cells
  2. Studies on the replicative capacity and aging of hematopoietic stem cells
  3. Studies on the plasticity and reprogramming of tissue-specific stem cells

Fig.1

Fig.2


Back